Control of occult hepatitis B virus infection

dc.contributor.authorLalana Garcés, Marta
dc.contributor.authorOrtiz Pastor, Oihana
dc.contributor.authorSolé Enrech, Gemma
dc.contributor.authorGuerra Ruiz, Armanado R.
dc.contributor.authorCasals Mercadal, Gregori
dc.contributor.authorAlmería Lafuente, Alejandro
dc.contributor.authorBallesteros Vizoso, María Antonieta
dc.contributor.authorGabriel Medina, Pablo
dc.contributor.authorSalgüero Fernández, Sergio
dc.contributor.authorZamora Trillo, Angielys
dc.contributor.authorAured de la Serna, Isabel
dc.contributor.authorHurtado, Juan Carlos
dc.contributor.authorPérez del Pulgar Gallart, Sofía
dc.contributor.authorForns, Xavier
dc.contributor.authorMorales Ruiz, Manuel
dc.date.accessioned2023-07-04T13:51:40Z
dc.date.available2023-07-04T13:51:40Z
dc.date.issued2022-08-15
dc.date.updated2023-07-03T09:50:34Z
dc.description.abstractBackground: The diagnosis of hepatitis B virus (HBV) infection requires HBV DNA testing and serologic testing for detection of the surface antigen (HBsAg) and the hepatitis B core antibody (anti-HBc). There is a population of patients with occult HBV infection (OBI), which is not detected by HBsAg or HBV DNA quantification in blood, despite the presence of active replication in the liver.Scope: This document provides a definition of OBI and describes the diagnostic techniques currently used. It also addresses the detection of patients with risk factors and the need for screening for OBI in these patients.Summary:Correct diagnosis of OBI prevents HBV reactivation and transmission. Diagnosis of OBI is based on the detection of HBV DNA in patients with undetectable HBsAg in blood.Perspectives: A high number of patients with OBI may remain undiagnosed; therefore, screening for OBI in patients with factor risks is essential. For a correct diagnosis of OBI, it is necessary that new markers such as ultrasensitive HBsAg are incorporated, and a more comprehensive marker study is performed by including markers such as cccDNA.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina9346686
dc.identifier.issn2628-491X
dc.identifier.pmid37363431
dc.identifier.urihttps://hdl.handle.net/2445/200265
dc.language.isoeng
dc.publisherDe Gruyter
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1515/almed-2022-0065
dc.relation.ispartofAdvances In Laboratory Medicine, 2022, vol. 3, num. 4, p. 321-330
dc.relation.urihttps://doi.org/10.1515/almed-2022-0065
dc.rightscc by (c) Lalana Garcés, Marta et al, 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject.classificationHepatitis B
dc.subject.classificationSerodiagnòstic
dc.subject.otherHepatitis B
dc.subject.otherSerodiagnosis
dc.titleControl of occult hepatitis B virus infection
dc.typeinfo:eu-repo/semantics/other
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Control of occult hepatitis B virus infection_AdvLabMed.pdf
Mida:
688.49 KB
Format:
Adobe Portable Document Format